Business Description
Bio-Path Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US09057N4097
Total Employee Number:
10Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -12.54 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45.6 | |||||
3-Year EPS without NRI Growth Rate | 45.6 | |||||
3-Year FCF Growth Rate | 47.1 | |||||
3-Year Book Growth Rate | -92.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.48 | |||||
9-Day RSI | 56.91 | |||||
14-Day RSI | 54.53 | |||||
3-1 Month Momentum % | -44.53 | |||||
6-1 Month Momentum % | -39.66 | |||||
12-1 Month Momentum % | -79.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -152.6 | |||||
Shareholder Yield % | -15.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -542.53 | |||||
ROIC % | -775.77 | |||||
3-Year ROIIC % | 89.64 | |||||
ROC (Joel Greenblatt) % | -8288.86 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.5 | |||||
EV-to-EBITDA | -0.5 | |||||
EV-to-FCF | -8.77 | |||||
Earnings Yield (Greenblatt) % | -200 | |||||
FCF Yield % | -13.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BPTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Path Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.69 | ||
| Beta | -1.3318 | ||
| 3-Year Sharpe Ratio | -1.21 | ||
| 3-Year Sortino Ratio | -1.49 | ||
| Volatility % | 118.43 | ||
| 14-Day RSI | 54.53 | ||
| 14-Day ATR ($) | 0.011215 | ||
| 20-Day SMA ($) | 0.038021 | ||
| 12-1 Month Momentum % | -79.51 | ||
| 52-Week Range ($) | 0.012 - 0.17 | ||
| Shares Outstanding (Mil) | 50.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Path Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Path Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2024-02-23 | 7.24 (-17.90%) | ||
| 0.05:1 Stock Split | 2019-01-18 | 50.40 (+0.80%) | ||
| 0.1:1 Stock Split | 2018-02-09 | 744.00 (-4.62%) |
Show
Entries
Bio-Path Holdings Inc Frequently Asked Questions
What is Bio-Path Holdings Inc(BPTH)'s stock price today?
The current price of BPTH is $0.05. The 52 week high of BPTH is $0.17 and 52 week low is $0.01.
When is next earnings date of Bio-Path Holdings Inc(BPTH)?
The next earnings date of Bio-Path Holdings Inc(BPTH) is .
Does Bio-Path Holdings Inc(BPTH) pay dividends? If so, how much?
Bio-Path Holdings Inc(BPTH) does not pay dividend.
Guru Commentaries on OTCPK:BPTH
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) | 2019-04-11 |
Articles on Bio-Path Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers